| __timestamp | Ascendis Pharma A/S | Verona Pharma plc |
|---|---|---|
| Wednesday, January 1, 2014 | 6274000 | 1802274 |
| Thursday, January 1, 2015 | 9415000 | 2512761 |
| Friday, January 1, 2016 | 11504000 | 2894488 |
| Sunday, January 1, 2017 | 13482000 | 8096274 |
| Monday, January 1, 2018 | 25057000 | 7985229 |
| Tuesday, January 1, 2019 | 48473000 | 8994597 |
| Wednesday, January 1, 2020 | 76669000 | 29772000 |
| Friday, January 1, 2021 | 160180000 | 33907000 |
| Saturday, January 1, 2022 | 221227000 | 26579000 |
| Sunday, January 1, 2023 | 264410000 | 49868547 |
| Monday, January 1, 2024 | 284545000 |
In pursuit of knowledge
In the competitive world of pharmaceuticals, operational efficiency is key. Ascendis Pharma A/S and Verona Pharma plc, two prominent players, have shown contrasting trends in their Selling, General, and Administrative (SG&A) expenses from 2014 to 2023. Ascendis Pharma A/S has seen a staggering increase of over 4,100% in SG&A expenses, peaking at approximately $264 million in 2023. This growth reflects their aggressive expansion and investment in operational capabilities. In contrast, Verona Pharma plc's SG&A expenses have grown by about 2,670%, reaching nearly $50 million in the same period. This more conservative increase suggests a strategic focus on cost management while still pursuing growth. These trends highlight the diverse strategies employed by pharmaceutical companies to navigate the complexities of the industry, balancing growth with operational efficiency.
Breaking Down SG&A Expenses: Merck & Co., Inc. vs Verona Pharma plc
Teva Pharmaceutical Industries Limited and Verona Pharma plc: SG&A Spending Patterns Compared
Cost Management Insights: SG&A Expenses for BeiGene, Ltd. and Verona Pharma plc
Who Optimizes SG&A Costs Better? Dr. Reddy's Laboratories Limited or Ascendis Pharma A/S
Ascendis Pharma A/S and Lantheus Holdings, Inc.: SG&A Spending Patterns Compared
Ascendis Pharma A/S or Xenon Pharmaceuticals Inc.: Who Manages SG&A Costs Better?
SG&A Efficiency Analysis: Comparing Ascendis Pharma A/S and PTC Therapeutics, Inc.
Who Optimizes SG&A Costs Better? Ascendis Pharma A/S or Galapagos NV
Ascendis Pharma A/S or Evotec SE: Who Manages SG&A Costs Better?
SG&A Efficiency Analysis: Comparing Halozyme Therapeutics, Inc. and Verona Pharma plc
Operational Costs Compared: SG&A Analysis of Verona Pharma plc and Protagonist Therapeutics, Inc.
Selling, General, and Administrative Costs: Verona Pharma plc vs Travere Therapeutics, Inc.